Raymond James Financial Services Advisors, Inc. Gritstone Bio, Inc. Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Gritstone Bio, Inc. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 19,873 shares of GRTS stock, worth $596. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,873

Previous 22,073 9.97%

Holding current value

$596

Previous $13,000 15.38%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$0.45 - $0.71 $990 - $1,562	-2,200 Reduced 9.97%	19,873 $11,000
Q4 2023 Jan 16, 2024	SELL	$1.28 - $2.85 $4,480 - $9,975	-3,500 Reduced 13.69%	22,073 $45,000
Q3 2023 Oct 24, 2023	SELL	$1.19 - $2.26 $476 - $903	-400 Reduced 1.54%	25,573 $43,000
Q1 2023 Apr 14, 2023	BUY	$2.13 - $3.74 $1,433 - $2,517	673 Added 2.66%	25,973 $72,000
Q4 2022 Feb 08, 2023	BUY	$2.17 - $3.92 $5,425 - $9,800	2,500 Added 10.96%	25,300 $87,000
Q3 2022 Oct 25, 2022	BUY	$2.46 - $4.75 $5,166 - $9,975	2,100 Added 10.14%	22,800 $59,000
Q2 2022 Aug 12, 2022	BUY	$1.77 - $4.34 $7,611 - $18,662	4,300 Added 26.22%	20,700 $50,000
Q1 2022 May 11, 2022	BUY	$4.03 - $12.19 $6,851 - $20,723	1,700 Added 11.56%	16,400 $68,000
Q4 2021 Feb 08, 2022	SELL	$8.76 - $13.71 $178,266 - $278,998	-20,350 Reduced 58.06%	14,700 $189,000
Q3 2021 Nov 02, 2021	BUY	$6.41 - $13.54 $74,676 - $157,741	11,650 Added 49.79%	35,050 $379,000
Q2 2021 Aug 11, 2021	SELL	$8.13 - $10.2 $3,252 - $4,079	-400 Reduced 1.68%	23,400 $214,000
Q1 2021 May 14, 2021	BUY	$4.07 - $27.11 $18,722 - $124,706	4,600 Added 23.96%	23,800 $224,000
Q4 2020 Feb 12, 2021	BUY	$2.57 - $4.22 $16,841 - $27,653	6,553 Added 51.81%	19,200 $76,000
Q3 2020 Nov 04, 2020	BUY	$2.63 - $8.09 $33,261 - $102,314	12,647 New	12,647 $34,000

Others Institutions Holding GRTS

# of Institutions

Shares Held

1.07M

Call Options Held

Put Options Held

View Full List

About Gritstone bio, Inc.

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

More about GRTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account

Raymond James Financial Services Advisors, Inc. Gritstone Bio, Inc. Transaction History